The 2011 Leading Pharmaceutical Companies R&D Expenditures and Major Programs

October 2010 | 160 pages | ID: LB1712841C3EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

For each company, the report provides:

• Annual R&D budget.
• Research facilities and staff.
• New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.

The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 160 pages